Filing Details

Accession Number:
0001883850-22-000018
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-03 16:19:39
Reporting Period:
2022-03-01
Accepted Time:
2022-03-03 16:19:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc. REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1187443 F Arthur Ryan 777 Old Saw Mill River Road
Tarrytown NY 10591
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-03-01 3 $607.28 22,479 No 4 S Direct
Common Stock Disposition 2022-03-01 2 $608.48 22,477 No 4 S Direct
Common Stock Disposition 2022-03-01 3 $609.61 22,474 No 4 S Direct
Common Stock Disposition 2022-03-01 3 $610.83 22,471 No 4 S Direct
Common Stock Disposition 2022-03-01 3 $611.04 22,468 No 4 S Direct
Common Stock Disposition 2022-03-01 3 $612.45 22,465 No 4 S Direct
Common Stock Disposition 2022-03-01 2 $613.82 22,463 No 4 S Direct
Common Stock Disposition 2022-03-01 4 $614.38 22,459 No 4 S Direct
Common Stock Disposition 2022-03-01 3 $615.45 22,456 No 4 S Direct
Common Stock Disposition 2022-03-01 7 $616.55 22,449 No 4 S Direct
Common Stock Disposition 2022-03-01 9 $617.66 22,440 No 4 S Direct
Common Stock Disposition 2022-03-01 3 $618.34 22,437 No 4 S Direct
Common Stock Disposition 2022-03-01 7 $619.40 22,430 No 4 S Direct
Common Stock Disposition 2022-03-01 6 $620.55 22,424 No 4 S Direct
Common Stock Disposition 2022-03-01 8 $621.43 22,416 No 4 S Direct
Common Stock Disposition 2022-03-01 21 $622.49 22,395 No 4 S Direct
Common Stock Disposition 2022-03-01 13 $623.23 22,382 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
  2. Represents volume-weighted average price of sales of 3 shares of Company stock on March 1, 2022 at prices ranging from $607.00 to $607.42. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2022 at each separate price.
  3. Represents volume-weighted average price of sales of 2 shares of Company stock on March 1, 2022 at prices ranging from $608.30 to $608.65. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2022 at each separate price.
  4. Represents volume-weighted average price of sales of 3 shares of Company stock on March 1, 2022 at prices ranging from $609.18 to $609.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2022 at each separate price.
  5. Represents volume-weighted average price of sales of 3 shares of Company stock on March 1, 2022 at prices ranging from $610.68 to $610.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2022 at each separate price.
  6. Represents volume-weighted average price of sales of 3 shares of Company stock on March 1, 2022 at prices ranging from $611.00 to $611.13. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2022 at each separate price.
  7. Represents volume-weighted average price of sales of 3 shares of Company stock on March 1, 2022 at prices ranging from $612.08 to $612.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2022 at each separate price.
  8. Represents volume-weighted average price of sales of 4 shares of Company stock on March 1, 2022 at prices ranging from $614.10 to $614.67. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2022 at each separate price.
  9. Represents volume-weighted average price of sales of 3 shares of Company stock on March 1, 2022 at prices ranging from $615.39 to $615.58. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2022 at each separate price.
  10. Represents volume-weighted average price of sales of 7 shares of Company stock on March 1, 2022 at prices ranging from $616.18 to $616.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2022 at each separate price.
  11. Represents volume-weighted average price of sales of 9 shares of Company stock on March 1, 2022 at prices ranging from $617.16 to $617.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2022 at each separate price.
  12. Represents volume-weighted average price of sales of 3 shares of Company stock on March 1, 2022 at prices ranging from $618.24 to $618.46. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2022 at each separate price.
  13. Represents volume-weighted average price of sales of 7 shares of Company stock on March 1, 2022 at prices ranging from $619.07 to $619.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2022 at each separate price.
  14. Represents volume-weighted average price of sales of 6 shares of Company stock on March 1, 2022 at prices ranging from $620.11 to $620.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2022 at each separate price.
  15. Represents volume-weighted average price of sales of 8 shares of Company stock on March 1, 2022 at prices ranging from $621.36 to $621.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2022 at each separate price.
  16. Represents volume-weighted average price of sales of 21 shares of Company stock on March 1, 2022 at prices ranging from $622.01 to $622.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2022 at each separate price.
  17. Represents volume-weighted average price of sales of 13 shares of Company stock on March 1, 2022 at prices ranging from $623.00 to $623.64. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 1, 2022 at each separate price.